CN Bio Innovations

40 employees

CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.

Basic info

biotechnology research

Biotechnology

COVID 19

Organ-on-Chip

Preclinical drug discovery

3D cell culture

PhysioMimix OOC

Aminal alternative

non-alcoholic steatohepatitis

ADME

New Alternative approaches

Medical Device

disease modeling

liver disease

Biopharma

Contract Research Services

Health Care

Microphysiological systems

non-alcoholic fatty liver disorder

Hepatitis B

drug discovery

Drug-induced liver injury

precision biology

containment level 3 laboratory

Safety Toxicology

microfluidic cell culture

Medical

Organ-on-a-chip

2009